STAT2

References

• O’Neill LA, Bowie AG. Sensing and signaling in antiviral innate immunity. Curr Biol 2010; 20:R328 - 33; http://dx.doi.org/10.1016/j.cub.2010.01.044; PMID: 20392426
   PubMed Web of Science ®Google Scholar
• Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004; 5:1219 - 26; http://dx.doi.org/10.1038/ni1141; PMID: 15549123
   PubMed Web of Science ®Google Scholar
• Barchet W, Cella M, Colonna M. Plasmacytoid dendritic cells--virus experts of innate immunity. Semin Immunol 2005; 17:253 - 61; http://dx.doi.org/10.1016/j.smim.2005.05.008; PMID: 15990333
   PubMed Web of Science ®Google Scholar
• Maher SG, Sheikh F, Scarzello AJ, Romero-Weaver AL, Baker DP, Donnelly RP, et al. IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity. Cancer Biol Ther 2008; 7:1109 - 15; http://dx.doi.org/10.4161/cbt.7.7.6192; PMID: 18698163
   PubMed Web of Science ®Google Scholar
• Zhou Z, Hamming OJ, Ank N, Paludan SR, Nielsen AL, Hartmann R. Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases. J Virol 2007; 81:7749 - 58; http://dx.doi.org/10.1128/JVI.02438-06; PMID: 17507495
   PubMed Web of Science ®Google Scholar
• Sadler AJ, Williams BR. Interferon-inducible antiviral effectors. Nat Rev Immunol 2008; 8:559 - 68; http://dx.doi.org/10.1038/nri2314; PMID: 18575461
   PubMed Web of Science ®Google Scholar
• Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998; 67:227 - 64; http://dx.doi.org/10.1146/annurev.biochem.67.1.227; PMID: 9759489
   PubMed Web of Science ®Google Scholar
• Gad HH, Dellgren C, Hamming OJ, Vends S, Paludan SR, Hartmann R. Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family. J Biol Chem 2009; 284:20869 - 75; http://dx.doi.org/10.1074/jbc.M109.002923; PMID: 19457860
   PubMed Web of Science ®Google Scholar
• Dellgren C, Gad HH, Hamming OJ, Melchjorsen J, Hartmann R. Human interferon-lambda3 is a potent member of the type III interferon family. Genes Immun 2009; 10:125 - 31; http://dx.doi.org/10.1038/gene.2008.87; PMID: 18987645
   PubMed Web of Science ®Google Scholar
• Bluyssen HA, Levy DE. Stat2 is a transcriptional activator that requires sequence-specific contacts provided by stat1 and p48 for stable interaction with DNA. J Biol Chem 1997; 272:4600 - 5; http://dx.doi.org/10.1074/jbc.272.7.4600; PMID: 9020188
   PubMed Web of Science ®Google Scholar
• Horvath CM, Stark GR, Kerr IM, Darnell JE Jr.. Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex. Mol Cell Biol 1996; 16:6957 - 64; PMID: 8943351
   PubMed Web of Science ®Google Scholar
• Ghislain JJ, Wong T, Nguyen M, Fish EN. The interferon-inducible Stat2:Stat1 heterodimer preferentially binds in vitro to a consensus element found in the promoters of a subset of interferon-stimulated genes. J Interferon Cytokine Res 2001; 21:379 - 88; http://dx.doi.org/10.1089/107999001750277853; PMID: 11440635
   PubMed Web of Science ®Google Scholar
• Brierley MM, Fish EN. Stats: multifaceted regulators of transcription. J Interferon Cytokine Res 2005; 25:733 - 44; http://dx.doi.org/10.1089/jir.2005.25.733; PMID: 16375601
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Tanaka N, Harada H, Kimura T, Yokochi T, Kitagawa M, et al. Activation of the transcription factor ISGF3 by interferon-gamma. Biol Chem 1999; 380:699 - 703; http://dx.doi.org/10.1515/BC.1999.087; PMID: 10430035
   PubMed Web of Science ®Google Scholar
• Davis AM, Hagan KA, Matthews LA, Bajwa G, Gill MA, Gale M Jr., et al. Blockade of virus infection by human CD4+ T cells via a cytokine relay network. J Immunol 2008; 180:6923 - 32; PMID: 18453613
   PubMed Web of Science ®Google Scholar
• Morrow AN, Schmeisser H, Tsuno T, Zoon KC. A novel role for IFN-stimulated gene factor 3II in IFN-γ signaling and induction of antiviral activity in human cells. J Immunol 2011; 186:1685 - 93; http://dx.doi.org/10.4049/jimmunol.1001359; PMID: 21178011
   PubMed Web of Science ®Google Scholar
• Park C, Li S, Cha E, Schindler C. Immune response in Stat2 knockout mice. Immunity 2000; 13:795 - 804; http://dx.doi.org/10.1016/S1074-7613(00)00077-7; PMID: 11163195
   PubMed Web of Science ®Google Scholar
• Jewell NA, Cline T, Mertz SE, Smirnov SV, Flaño E, Schindler C, et al. Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J Virol 2010; 84:11515 - 22; http://dx.doi.org/10.1128/JVI.01703-09; PMID: 20739515
   PubMed Web of Science ®Google Scholar
• Wu S, Metcalf JP, Wu W. Innate immune response to influenza virus. Curr Opin Infect Dis 2011; 24:235 - 40; http://dx.doi.org/10.1097/QCO.0b013e328344c0e3; PMID: 21330918
   PubMed Web of Science ®Google Scholar
• Silverman RH. Viral encounters with 2′,5′-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol 2007; 81:12720 - 9; http://dx.doi.org/10.1128/JVI.01471-07; PMID: 17804500
   PubMed Web of Science ®Google Scholar
• de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, et al. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 2001; 69:912 - 20; PMID: 11404376
   PubMed Web of Science ®Google Scholar
• Haller O, Kochs G. Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J Interferon Cytokine Res 2011; 31:79 - 87; http://dx.doi.org/10.1089/jir.2010.0076; PMID: 21166595
   PubMed Web of Science ®Google Scholar
• Schoggins JW, Rice CM. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 2011; 1:519 - 25; http://dx.doi.org/10.1016/j.coviro.2011.10.008; PMID: 22328912
   PubMed Web of Science ®Google Scholar
• Steen HC, Gamero AM. The role of signal transducer and activator of transcription-2 in the interferon response. J Interferon Cytokine Res 2012; 32:103 - 10; PMID: 22280068
   PubMed Web of Science ®Google Scholar
• Gamero AM, Potla R, Wegrzyn J, Szelag M, Edling AE, Shimoda K, et al. Activation of Tyk2 and Stat3 is required for the apoptotic actions of interferon-beta in primary pro-B cells. J Biol Chem 2006; 281:16238 - 44; http://dx.doi.org/10.1074/jbc.M509516200; PMID: 16601124
   PubMed Web of Science ®Google Scholar
• Gamero AM, Potla R, Sakamoto S, Baker DP, Abraham R, Larner AC. Type I interferons activate apoptosis in a Jurkat cell variant by caspase-dependent and independent mechanisms. Cell Signal 2006; 18:1299 - 308; http://dx.doi.org/10.1016/j.cellsig.2005.10.008; PMID: 16337360
   PubMed Web of Science ®Google Scholar
• Maher SG, Romero-Weaver AL, Scarzello AJ, Gamero AM. Interferon: cellular executioner or white knight?. Curr Med Chem 2007; 14:1279 - 89; http://dx.doi.org/10.2174/092986707780597907; PMID: 17504213
   PubMed Web of Science ®Google Scholar
• Scarzello AJ, Romero-Weaver AL, Maher SG, Veenstra TD, Zhou M, Qin A, et al. A Mutation in the SH2 domain of STAT2 prolongs tyrosine phosphorylation of STAT1 and promotes type I IFN-induced apoptosis. Mol Biol Cell 2007; 18:2455 - 62; http://dx.doi.org/10.1091/mbc.E06-09-0843; PMID: 17442890
   PubMed Web of Science ®Google Scholar
• Filipe-Santos O, Bustamante J, Haverkamp MH, Vinolo E, Ku CL, Puel A, et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med 2006; 203:1745 - 59; http://dx.doi.org/10.1084/jem.20060085; PMID: 16818673
   PubMed Web of Science ®Google Scholar
• Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 2006; 25:745 - 55; http://dx.doi.org/10.1016/j.immuni.2006.09.009; PMID: 17088085
   PubMed Web of Science ®Google Scholar
• Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007; 317:1522 - 7; http://dx.doi.org/10.1126/science.1139522; PMID: 17872438
   PubMed Web of Science ®Google Scholar
• Casrouge A, Zhang SY, Eidenschenk C, Jouanguy E, Puel A, Yang K, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006; 314:308 - 12; http://dx.doi.org/10.1126/science.1128346; PMID: 16973841
   PubMed Web of Science ®Google Scholar
• Zhang SY, Boisson-Dupuis S, Chapgier A, Yang K, Bustamante J, Puel A, et al. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. Immunol Rev 2008; 226:29 - 40; http://dx.doi.org/10.1111/j.1600-065X.2008.00698.x; PMID: 19161414
   PubMed Web of Science ®Google Scholar
• Casanova JL, Holland SM, Notarangelo LD. Inborn errors of human JAKs and STATs. Immunity 2012; 36:515 - 28; http://dx.doi.org/10.1016/j.immuni.2012.03.016; PMID: 22520845
   PubMed Web of Science ®Google Scholar
• Murray PJ. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol 2006; 6:379 - 86; http://dx.doi.org/10.1016/j.coph.2006.01.010; PMID: 16713356
   PubMed Web of Science ®Google Scholar
• Hodge DR, Hurt EM, Farrar WL. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 2005; 41:2502 - 12; http://dx.doi.org/10.1016/j.ejca.2005.08.016; PMID: 16199153
   PubMed Web of Science ®Google Scholar
• Rogge L, D’Ambrosio D, Biffi M, Penna G, Minetti LJ, Presky DH, et al. The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol 1998; 161:6567 - 74; PMID: 9862683
   PubMed Web of Science ®Google Scholar
• Farrar JD, Smith JD, Murphy TL, Murphy KM. Recruitment of Stat4 to the human interferon-alpha/beta receptor requires activated Stat2. J Biol Chem 2000; 275:2693 - 7; http://dx.doi.org/10.1074/jbc.275.4.2693; PMID: 10644731
   PubMed Web of Science ®Google Scholar
• Ramos HJ, Davis AM, George TC, Farrar JD. IFN-alpha is not sufficient to drive Th1 development due to lack of stable T-bet expression. J Immunol 2007; 179:3792 - 803; PMID: 17785816
   PubMed Web of Science ®Google Scholar
• Berenson LS, Farrar JD, Murphy TL, Murphy KM. Frontline: absence of functional STAT4 activation despite detectable tyrosine phosphorylation induced by murine IFN-alpha. Eur J Immunol 2004; 34:2365 - 74; http://dx.doi.org/10.1002/eji.200324829; PMID: 15307169
   PubMed Web of Science ®Google Scholar
• Kraus TA, Garza L, Horvath CM. Enabled interferon signaling evasion in an immune-competent transgenic mouse model of parainfluenza virus 5 infection. Virology 2008; 371:196 - 205; http://dx.doi.org/10.1016/j.virol.2007.10.001; PMID: 17964629
   PubMed Web of Science ®Google Scholar
• Wang J, Pham-Mitchell N, Schindler C, Campbell IL. Dysregulated Sonic hedgehog signaling and medulloblastoma consequent to IFN-alpha-stimulated STAT2-independent production of IFN-gamma in the brain. J Clin Invest 2003; 112:535 - 43; PMID: 12925694
   PubMed Web of Science ®Google Scholar
• Ramos HJ, Davis AM, Cole AG, Schatzle JD, Forman J, Farrar JD. Reciprocal responsiveness to interleukin-12 and interferon-alpha specifies human CD8+ effector versus central memory T-cell fates. Blood 2009; 113:5516 - 25; http://dx.doi.org/10.1182/blood-2008-11-188458; PMID: 19299334
   PubMed Web of Science ®Google Scholar
• Huber JP, Farrar JD. Regulation of effector and memory T-cell functions by type I interferon. Immunology 2011; 132:466 - 74; http://dx.doi.org/10.1111/j.1365-2567.2011.03412.x; PMID: 21320124
   PubMed Web of Science ®Google Scholar
• Chowdhury FZ, Ramos HJ, Davis LS, Forman J, Farrar JD. IL-12 selectively programs effector pathways that are stably expressed in human CD8+ effector memory T cells in vivo. Blood 2011; 118:3890 - 900; http://dx.doi.org/10.1182/blood-2011-05-357111; PMID: 21832277
   PubMed Web of Science ®Google Scholar
• Athie-Morales V, Smits HH, Cantrell DA, Hilkens CM. Sustained IL-12 signaling is required for Th1 development. J Immunol 2004; 172:61 - 9; PMID: 14688310
   PubMed Web of Science ®Google Scholar
• Berenson LS, Gavrieli M, Farrar JD, Murphy TL, Murphy KM. Distinct characteristics of murine STAT4 activation in response to IL-12 and IFN-alpha. J Immunol 2006; 177:5195 - 203; PMID: 17015705
   PubMed Web of Science ®Google Scholar
• Lu B, Nakamura T, Inouye K, Li J, Tang Y, Lundbäck P, et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature 2012; 488:670 - 4; http://dx.doi.org/10.1038/nature11290; PMID: 22801494
   PubMed Web of Science ®Google Scholar
• Gamero AM, Young MR, Mentor-Marcel R, Bobe G, Scarzello AJ, Wise J, et al. STAT2 contributes to promotion of colorectal and skin carcinogenesis. Cancer Prev Res (Phila) 2010; 3:495 - 504; http://dx.doi.org/10.1158/1940-6207.CAPR-09-0105; PMID: 20233899
   PubMed Web of Science ®Google Scholar
• Kadeppagari R-K, Sanchez RL, Foster TP. HSV-2 inhibits type-I interferon signaling via multiple complementary and compensatory STAT2-associated mechanisms. Virus Res 2012; 167:273 - 84; http://dx.doi.org/10.1016/j.virusres.2012.05.010; PMID: 22634037
   PubMed Web of Science ®Google Scholar
• Zimmermann A, Trilling M, Wagner M, Wilborn M, Bubic I, Jonjic S, et al. A cytomegaloviral protein reveals a dual role for STAT2 in IFN-gamma signaling and antiviral responses. J Exp Med 2005; 201:1543 - 53; http://dx.doi.org/10.1084/jem.20041401; PMID: 15883169
   PubMed Web of Science ®Google Scholar
• Hahm B, Trifilo MJ, Zuniga EI, Oldstone MBA. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 2005; 22:247 - 57; http://dx.doi.org/10.1016/j.immuni.2005.01.005; PMID: 15723812
   PubMed Web of Science ®Google Scholar
• Rodriguez JJ, Horvath CM. Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus v proteins inhibit interferon signaling. Viral Immunol 2004; 17:210 - 9; http://dx.doi.org/10.1089/0882824041310568; PMID: 15279700
   PubMed Web of Science ®Google Scholar
• Ramachandran A, Parisien J-P, Horvath CM. STAT2 is a primary target for measles virus V protein-mediated alpha/beta interferon signaling inhibition. J Virol 2008; 82:8330 - 8; http://dx.doi.org/10.1128/JVI.00831-08; PMID: 18579593
   PubMed Web of Science ®Google Scholar
• Ramachandran A, Horvath CM. Paramyxovirus disruption of interferon signal transduction: STATus report. J Interferon Cytokine Res 2009; 29:531 - 7; http://dx.doi.org/10.1089/jir.2009.0070; PMID: 19694544
   PubMed Web of Science ®Google Scholar
• Wang LF, Michalski WP, Yu M, Pritchard LI, Crameri G, Shiell B, et al. A novel P/V/C gene in a new member of the Paramyxoviridae family, which causes lethal infection in humans, horses, and other animals. J Virol 1998; 72:1482 - 90; PMID: 9445051
   PubMed Web of Science ®Google Scholar
• Rodriguez JJ, Parisien J-P, Horvath CM. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J Virol 2002; 76:11476 - 83; http://dx.doi.org/10.1128/JVI.76.22.11476-11483.2002; PMID: 12388709
   PubMed Web of Science ®Google Scholar
• Rodriguez JJ, Cruz CD, Horvath CM. Identification of the nuclear export signal and STAT-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion. J Virol 2004; 78:5358 - 67; http://dx.doi.org/10.1128/JVI.78.10.5358-5367.2004; PMID: 15113915
   PubMed Web of Science ®Google Scholar
• Rodriguez JJ, Wang LF, Horvath CM. Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation. J Virol 2003; 77:11842 - 5; http://dx.doi.org/10.1128/JVI.77.21.11842-11845.2003; PMID: 14557668
   PubMed Web of Science ®Google Scholar
• Lo MS, Brazas RM, Holtzman MJ. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol 2005; 79:9315 - 9; http://dx.doi.org/10.1128/JVI.79.14.9315-9319.2005; PMID: 15994826
   PubMed Web of Science ®Google Scholar
• Swedan S, Musiyenko A, Barik S. Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways. J Virol 2009; 83:9682 - 93; http://dx.doi.org/10.1128/JVI.00715-09; PMID: 19625398
   PubMed Web of Science ®Google Scholar
• Ramaswamy M, Shi L, Varga SM, Barik S, Behlke MA, Look DC. Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 2006; 344:328 - 39; http://dx.doi.org/10.1016/j.virol.2005.09.009; PMID: 16216295
   PubMed Web of Science ®Google Scholar
• Elliott J, Lynch OT, Suessmuth Y, Qian P, Boyd CR, Burrows JF, et al. Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase. J Virol 2007; 81:3428 - 36; http://dx.doi.org/10.1128/JVI.02303-06; PMID: 17251292
   PubMed Web of Science ®Google Scholar
• Gotoh B, Takeuchi K, Komatsu T, Yokoo J. The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling. J Virol 2003; 77:3360 - 70; http://dx.doi.org/10.1128/JVI.77.6.3360-3370.2003; PMID: 12610111
   PubMed Web of Science ®Google Scholar
• Parisien JP, Lau JF, Rodriguez JJ, Sullivan BM, Moscona A, Parks GD, et al. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology 2001; 283:230 - 9; http://dx.doi.org/10.1006/viro.2001.0856; PMID: 11336548
   PubMed Web of Science ®Google Scholar
• Parisien J-P, Lau JF, Rodriguez JJ, Ulane CM, Horvath CM. Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction. J Virol 2002; 76:4190 - 8; http://dx.doi.org/10.1128/JVI.76.9.4190-4198.2002; PMID: 11932384
   PubMed Web of Science ®Google Scholar
• Parisien J-P, Lau JF, Horvath CM. STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication. J Virol 2002; 76:6435 - 41; http://dx.doi.org/10.1128/JVI.76.13.6435-6441.2002; PMID: 12050355
   PubMed Web of Science ®Google Scholar
• Morrison J, Aguirre S, Fernandez-Sesma A. Innate immunity evasion by Dengue virus. Viruses 2012; 4:397 - 413; http://dx.doi.org/10.3390/v4030397; PMID: 22590678
   PubMed Web of Science ®Google Scholar
• Jones M, Davidson A, Hibbert L, Gruenwald P, Schlaak J, Ball S, et al. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol 2005; 79:5414 - 20; http://dx.doi.org/10.1128/JVI.79.9.5414-5420.2005; PMID: 15827155
   PubMed Web of Science ®Google Scholar
• Ashour J, Laurent-Rolle M, Shi P-Y, García-Sastre A. NS5 of dengue virus mediates STAT2 binding and degradation. J Virol 2009; 83:5408 - 18; http://dx.doi.org/10.1128/JVI.02188-08; PMID: 19279106
   PubMed Web of Science ®Google Scholar
• Ashour J, Morrison J, Laurent-Rolle M, Belicha-Villanueva A, Plumlee CR, Bernal-Rubio D, et al. Mouse STAT2 restricts early dengue virus replication. Cell Host Microbe 2010; 8:410 - 21; http://dx.doi.org/10.1016/j.chom.2010.10.007; PMID: 21075352
   PubMed Web of Science ®Google Scholar
• Mazzon M, Jones M, Davidson A, Chain B, Jacobs M. Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J Infect Dis 2009; 200:1261 - 70; http://dx.doi.org/10.1086/605847; PMID: 19754307
   PubMed Web of Science ®Google Scholar
• Schoggins JW, Dorner M, Feulner M, Imanaka N, Murphy MY, Ploss A, et al. Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc Natl Acad Sci U S A 2012; 109:14610 - 5; http://dx.doi.org/10.1073/pnas.1212379109; PMID: 22908290
   PubMed Web of Science ®Google Scholar
• Kawata T, Shevchenko A, Fukuzawa M, Jermyn KA, Totty NF, Zhukovskaya NV, et al. SH2 signaling in a lower eukaryote: a STAT protein that regulates stalk cell differentiation in dictyostelium. Cell 1997; 89:909 - 16; http://dx.doi.org/10.1016/S0092-8674(00)80276-7; PMID: 9200609
   PubMed Web of Science ®Google Scholar
• Wang Y, Levy DE. Comparative evolutionary genomics of the STAT family of transcription factors. JAK-STAT 2012; 1:23 - 33; http://dx.doi.org/10.4161/jkst.19418
   PubMedGoogle Scholar
• Park C, Lecomte MJ, Schindler C. Murine Stat2 is uncharacteristically divergent. Nucleic Acids Res 1999; 27:4191 - 9; http://dx.doi.org/10.1093/nar/27.21.4191; PMID: 10518610
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D’Andrea A, et al. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature 1996; 383:344 - 7; http://dx.doi.org/10.1038/383344a0; PMID: 8848048
   PubMed Web of Science ®Google Scholar
• Farrar JD, Smith JD, Murphy TL, Leung S, Stark GR, Murphy KM. Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2. Nat Immunol 2000; 1:65 - 9; http://dx.doi.org/10.1038/76932; PMID: 10881177
   PubMed Web of Science ®Google Scholar
• Tyler DR, Persky ME, Matthews LA, Chan S, Farrar JD. Pre-assembly of STAT4 with the human IFN-alpha/beta receptor-2 subunit is mediated by the STAT4 N-domain. Mol Immunol 2007; 44:1864 - 72; http://dx.doi.org/10.1016/j.molimm.2006.10.006; PMID: 17095088
   PubMed Web of Science ®Google Scholar
• Persky ME, Murphy KM, Farrar JD. IL-12, but not IFN-alpha, promotes STAT4 activation and Th1 development in murine CD4+ T cells expressing a chimeric murine/human Stat2 gene. J Immunol 2005; 174:294 - 301; PMID: 15611252
   PubMed Web of Science ®Google Scholar
• Wojciak JM, Martinez-Yamout MA, Dyson HJ, Wright PE. Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domains. EMBO J 2009; 28:948 - 58; http://dx.doi.org/10.1038/emboj.2009.30; PMID: 19214187
   PubMed Web of Science ®Google Scholar
• Mendez FL, Watkins JC, Hammer MF. A haplotype at STAT2 Introgressed from neanderthals and serves as a candidate of positive selection in Papua New Guinea. Am J Hum Genet 2012; 91:265 - 74; http://dx.doi.org/10.1016/j.ajhg.2012.06.015; PMID: 22883142
   PubMed Web of Science ®Google Scholar
• Lin RJ, Liao CL, Lin E, Lin YL. Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. J Virol 2004; 78:9285 - 94; http://dx.doi.org/10.1128/JVI.78.17.9285-9294.2004; PMID: 15308723
   PubMed Web of Science ®Google Scholar
• Best SM, Morris KL, Shannon JG, Robertson SJ, Mitzel DN, Park GS, et al. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol 2005; 79:12828 - 39; http://dx.doi.org/10.1128/JVI.79.20.12828-12839.2005; PMID: 16188985
   PubMed Web of Science ®Google Scholar